After a rare view inside the world of professional sports and orthopedic medicine through a clinical rotation with the Houston Texans this summer, Analisa Narro, a fourth-year student with McGovern Medical School at UTHealth Houston, brought back key lessons from the enriching experience.
HTA changes at EU level could slow the uptake of new cell and gene therapies, industry group warns
If a cell or gene therapy developer wants to bring a new product to market in Europe, first they have to clear the EMA, and